168 related articles for article (PubMed ID: 30902584)
1. Repeat surgery in HNF1alpha-inactivated adenomatosis.
Balabaud C; Laurent C; Frulio N; Marie Christine SP; Le Bail B; Possenti L; Blanc JF; Chiche L; Bioulac-Sage P
Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):460-467. PubMed ID: 30902584
[TBL] [Abstract][Full Text] [Related]
2. Unexpected discovery of small HNF1α-inactivated hepatocellular adenoma in pathological specimens from patients resected for liver tumours.
Balabaud C; Laurent C; Le Bail B; Castain C; Possenti L; Frulio N; Chiche L; Blanc JF; Bioulac-Sage P
Liver Int; 2018 Jul; 38(7):1273-1279. PubMed ID: 29265678
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.
Bioulac-Sage P; Laumonier H; Couchy G; Le Bail B; Sa Cunha A; Rullier A; Laurent C; Blanc JF; Cubel G; Trillaud H; Zucman-Rossi J; Balabaud C; Saric J
Hepatology; 2009 Aug; 50(2):481-9. PubMed ID: 19585623
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of inflammatory hepatocellular adenomas with HNF1α-inactivated adenomas: is there an association?
Castain C; Sempoux C; Brunt EM; Causse O; Heitzmann A; Hernandez-Prera JC; Le Bail B; Schirmacher P; Thung SN; Balabaud C; Bioulac-Sage P
Histopathology; 2014 May; 64(6):890-5. PubMed ID: 24236804
[TBL] [Abstract][Full Text] [Related]
5. Natural history of liver adenomatosis: A long-term observational study.
Barbier L; Nault JC; Dujardin F; Scotto B; Besson M; de Muret A; Bourlier P; Zucman-Rossi J; Salamé E; Bacq Y
J Hepatol; 2019 Dec; 71(6):1184-1192. PubMed ID: 31419515
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular adenomas in the Turkish population: reclassification according to updated World Health Organization criteria.
Deniz K; Umetsu SE; Ferrell L; Yılmaz F; Güllüoğlu M; Sağol Ö; Doğusoy GB; Kırımlıoğlu H; Turhan N; Doran F; Kepil N; Çelikel ÇA; Nart D; Özgüven BY; Ceyran B; Karadağ N; Kır G; Erden E; Yılmaz G; Akyol G
Histopathology; 2021 Jul; 79(1):23-33. PubMed ID: 33406290
[TBL] [Abstract][Full Text] [Related]
7. Association of CYP1B1 germ line mutations with hepatocyte nuclear factor 1alpha-mutated hepatocellular adenoma.
Jeannot E; Poussin K; Chiche L; Bacq Y; Sturm N; Scoazec JY; Buffet C; Van Nhieu JT; Bellanné-Chantelot C; de Toma C; Laurent-Puig P; Bioulac-Sage P; Zucman-Rossi J
Cancer Res; 2007 Mar; 67(6):2611-6. PubMed ID: 17363580
[TBL] [Abstract][Full Text] [Related]
8. Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings.
Laumonier H; Cailliez H; Balabaud C; Possenti L; Zucman-Rossi J; Bioulac-Sage P; Trillaud H
AJR Am J Roentgenol; 2012 Aug; 199(2):341-8. PubMed ID: 22826395
[TBL] [Abstract][Full Text] [Related]
9. [Hepatocellular carcinoma in an inflammatory adenoma with β-catenin mutation in a patient with hepatocellular adenomatosis due to germline mutation in HNF1α].
Ridder DA; Duret D; Wörns MA; Schotten S; Heinrich S; Kloth M; Springer E; Roth W; Straub BK
Z Gastroenterol; 2019 Jan; 57(1):46-51. PubMed ID: 30641602
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular adenomatosis: what should the term stand for!
Frulio N; Chiche L; Bioulac-Sage P; Balabaud C
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):132-6. PubMed ID: 24126236
[TBL] [Abstract][Full Text] [Related]
11. Unique genetic alterations and clinicopathological features of hepatocellular adenoma in Chinese population.
Liu HP; Zhao Q; Jin GZ; Qian YW; Gu YJ; Dong H; Lu XY; Cong WM; Wu MC
Pathol Res Pract; 2015 Dec; 211(12):918-24. PubMed ID: 26608415
[TBL] [Abstract][Full Text] [Related]
12. Retrospective study of hepatocellular adenomas based on the phenotypic classification system: A report from China.
Pan J; Chen L; Fan J; Zhou J; Qin L; Tan Y; Ji Y; Huang X
Histol Histopathol; 2014 Feb; 29(2):243-9. PubMed ID: 23939475
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular Adenomas: Morphology and Genomics.
Bioulac-Sage P; Sempoux C; Balabaud C
Gastroenterol Clin North Am; 2017 Jun; 46(2):253-272. PubMed ID: 28506364
[TBL] [Abstract][Full Text] [Related]
14. Changing trends in malignant transformation of hepatocellular adenoma.
Farges O; Ferreira N; Dokmak S; Belghiti J; Bedossa P; Paradis V
Gut; 2011 Jan; 60(1):85-9. PubMed ID: 21148580
[TBL] [Abstract][Full Text] [Related]
15. Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis.
Pelletier L; Rebouissou S; Paris A; Rathahao-Paris E; Perdu E; Bioulac-Sage P; Imbeaud S; Zucman-Rossi J
Hepatology; 2010 Feb; 51(2):557-66. PubMed ID: 20041408
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous occurrence of focal nodular hyperplasia and HNF1A-inactivated hepatocellular adenoma: a collision tumor simulating a composite FNH-HCA.
Shih A; Lauwers GY; Balabaud C; Bioulac-Sage P; Misdraji J
Am J Surg Pathol; 2015 Sep; 39(9):1296-300. PubMed ID: 26274031
[TBL] [Abstract][Full Text] [Related]
17. New MRI features improve subtype classification of hepatocellular adenoma.
Bise S; Frulio N; Hocquelet A; Alberti N; Blanc JF; Laurent C; Laumonier H; Balabaud C; Bioulac-Sage P; Trillaud H
Eur Radiol; 2019 May; 29(5):2436-2447. PubMed ID: 30523457
[TBL] [Abstract][Full Text] [Related]
18. Limited added value of contrast-enhanced ultrasound over B-mode for the subtyping of hepatocellular adenomas.
Gregory J; Paisant A; Paulatto L; Raynaud L; Bertin C; Kerbaol A; Vullierme MP; Paradis V; Vilgrain V; Ronot M
Eur J Radiol; 2020 Jul; 128():109027. PubMed ID: 32361381
[TBL] [Abstract][Full Text] [Related]
19. Steatohepatitis-Like Changes in Hepatocellular Adenoma.
Liu Y; Zen Y; Yeh MM
Am J Clin Pathol; 2020 Sep; 154(4):525-532. PubMed ID: 32561910
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of liver resection for haemorrhagic hepatocellular adenoma.
Addeo P; Cesaretti M; Fuchshuber P; Langella S; Simone G; Oussoultzoglou E; Bachellier P
Int J Surg; 2016 Mar; 27():34-38. PubMed ID: 26805568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
